Balchem posts record Q3 2026 sales and earnings, repurchases $28 million of stock
Balchem Corporation reported third‑quarter 2026 net sales of $290.7 million, an 8.6% year‑over‑year increase. GAAP net earnings rose to $46.7 million, a 16.0% gain versus the same quarter last year, while adjusted EBITDA grew 12.4% to $80.3 million. Adjusted diluted EPS reached $1.57, up from $1.35 a year earlier, and the company bought back about $28 million of common shares during the quarter.
Why it matters
The stronger earnings and cash flow support Balchem’s ongoing share‑repurchase program, which may enhance shareholder returns. Analysts note that the continued rise in adjusted EBITDA for a 29th straight quarter signals durable profitability growth.
Key facts
- 1Net sales were $290.7 million, an increase of 8.6% from the prior‑year quarter. stocktitan.net
- 2GAAP net earnings were $46.7 million, a 16.0% rise from the prior‑year quarter. stocktitan.net
- 3Adjusted EBITDA was $80.3 million, up 12.4% from the prior‑year quarter. stocktitan.net
- 4Adjusted diluted earnings per share were $1.57, compared with $1.35 a year earlier. stocktitan.net
- 5The company repurchased approximately $28 million of common stock during the quarter. stocktitan.net
- 6Shares traded at $174.65, up 0.82% from the prior close. investing.com
Summary written by AlphAI AI Desk from 6 of 6 sources. Not investment advice. Figures are as stated by the linked sources.